글로벌 피부과 약물 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

피부과 약물 시장 분석

글로벌 피부과 약물 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 글로벌 피부과 약물 시장은 피부 질환을 탐지하고 치료하기 위한 의료 자원의 가용성과 같은 추진 요인으로 인해 성장할 것으로 예상되며 시장 성장이 증가할 것으로 예상됩니다. COVID-19도 시장 성장에 영향을 미쳤습니다.

피부과 약물 시장 규모

글로벌 피부과 약물 시장 규모는 2023년에 2,079만 달러로 평가되었으며, 2031년까지 453억 7,000만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 10.25%입니다.

보고 범위 및 시장 세분화       

Dermatology Drugs Market Definition

Dermatology is a therapy area dealing with skin, hair, and nails diseases, where the most common conditions are psoriasis, eczema, and acne vulgaris. Dermatology drugs are used to manage and treat diseases related to skin, nail, hair, and genital membranes. 

Dermatology Drugs Market Dynamics

Drivers

• Rise in Clinical Studies

The dermatologicals market is expected to rise as more clinical studies are conducted to assess the efficacy and safety of a variety of medicinal medications. For instance, the pharmaceutical company Amgen Inc. announced the favourable findings of a phase 3 placebo-controlled, double-blind clinical research in December 2021. The trial's objective is to evaluate Otezla's effectiveness in managing moderate to severe psoriasis.

Opportunities

• Increasing Elderly Population

The development of the dermatological pharmaceuticals market is fueled by the loss of human skin's ability to function properly with ageing, leading to numerous skin illnesses. Additionally, as we age, the body begins to experience several additional issues, including slower wound healing, increased sensitivity to ultraviolet (UV) radiation, increased susceptibility to infections, and decreased subcutaneous fat. Due to the increased likelihood of numerous skin conditions, the need for dermatological medications has skyrocketed.

Restraints/Challenges

• High Cost

The huge expenditure associated with these drugs surely hamper the market growth. Several market players make huge investments in manufacturing new drugs to faster the recovery process; in return, the cost is increased.

This global dermatology drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global dermatology drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Dermatology Drugs Market Scope

The global dermatology drugs market is segmented on the basis of type, technology and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Dermatological Diseases

• Acne
• Dermatitis
• Psoriasis
• Skin Cancer
• Others

Prescription mode 

• Prescription Based Drugs
• Over Counter Drugs

Drug Classification

• Corticosteroids
• Astringents
• Anti-Inflammatory & Antipruritic Drugs
• Anti-Infective/Antibacterial Drugs
• Antifungal Drugs

Route of Administration

• Topical
• Oral
• Parenteral Administration

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

End-User

• Hospitals
• Speciality Clinics
• Cosmetic Centres

 Dermatology Drugs Market Regional Analysis

The global dermatology drugs market is analysed and market size insights and trends are provided by type, technology and end-user as referenced above.

The major countries covered in the global dermatology drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Europe and Asia-Pacific dominate the dermatology drugs market due to rising skin disease awareness, a growing number of patients suffering from acne, vitiligo, and dermatitis, a growing patient pool of a wide range of dermatological conditions, and patients' willingness to pay for expensive medications in these regions.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Dermatology Drugs Market Share

The global dermatology drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global dermatology drugs market

Dermatology Drugs Market Leaders Operating in the Market Are:

• LUPIN (India)
• Novartis AG (Switzerland)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Pfizer Inc. (U.S.)
• Sanofi (France)
• Amgen inc. (U.S.)
• Lilly (U.S.)
• AstraZeneca (U.K.)
• AbbVie Inc (U.S.)
• Johnson & Johnson Private Limited (U.S.)
• LEO Pharma A/S (Denmark)
• Merck & Co., Inc (U.S.)
• Bausch Health Companies Inc (Canada)
• Bristol-Myers Squibb Company (U.S.)

Latest Developments in Dermatology Drugs Market

고품질 저렴한 셀프케어 제품을 공급하는 세계적 기업인 페리고 컴퍼니(Perrigo Company plc)는 2020년 4월 사노피로부터 동유럽의 OTC 스킨케어 및 탈모 치료제 브랜드 3개(에몰리움(Emolium), 이워스틴(Iwostin), 로크손(Loxon))를 인수했다고 발표했습니다.  

SKU-10578